Ignite Creation Date:
2025-12-26 @ 11:47 AM
Ignite Modification Date:
2025-12-26 @ 11:47 AM
Study NCT ID:
NCT02207816
Status:
COMPLETED
Last Update Posted:
2019-11-25
First Post:
2014-07-31
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
An Extension to Study MALARIA-055 PRI (NCT00866619) to Evaluate the Long-term Efficacy, Safety and Immunogenicity of GSK Biologicals' Candidate Malaria Vaccine in Infants and Children in Africa
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09-18
Start Date Type:
ACTUAL
Primary Completion Date:
2017-01-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-01-31
Completion Date Type:
ACTUAL
First Submit Date:
2014-07-31
First Submit QC Date:
None
Study First Post Date:
2014-08-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-01-29
Results First Submit QC Date:
None
Results First Post Date:
2019-08-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-14
Last Update Post Date:
2019-11-25
Last Update Post Date Type:
ACTUAL